6 results about "Allergy" patented technology

The conjugate compositions and methods are useful to elicit/augment an immune response to a tumor or microbial infection or to reduce the severity of autoimmunity, chronic inflammation, allergy, asthma, periodontal disease, and transplant rejection.

The present invention provides a rheumatism plaster, a thread-gluing breathable bag for packing rheumatism plaster and a production method thereof. The rheumatism plaster includes the following raw materials such as dried pinellia tuber, dried bile arisaema, dried szechuan aconite, dried kusezoff monkshood root, dried nux vomica, sesame oil and yellow lead. The rheumatism plaster is obtained through the following method: a required amount of sesame oil is boiled; then a required amount of dried pinellia tuber, dried bile arisaema, dried szechuan aconite, dried kusezoff monkshood root and dried nux vomica are mixed, poured into boiling sesame oil and fried with mild fire until the drug turns black and carbonized; herb residues are removed after fire is extinguished and a required amount of yellow lead is poured and evenly mixed after the sesame oil cools without boiling. The present invention adopts high-temperature sesame oil to make decoction of the five drugs, so that the toxicity disappears without decreasing the pharmacodynamical effect. The pharmacodynamical ingredients can be fully fried out; in addition, the quality of sesame oil is sticky, the sesame oil gradually dilutes in normal temperature of human body, the pharmacodynamical effect gradually releases and the plaster does not infiltrates the gauze and attach on the skin, so that the present invention achieves the aim of curing rheumatism without allergy. Besides, the present invention also has simple structure and convenient use.

The invention belongs to the field of daily chemical products, particularly relates to bacteriostatic foot powder and a preparation method thereof, and provides bacteriostatic foot powder. The bacteriostatic foot powder comprises the following components in percentages by weight: alkannin 1-3%, cinnaldehydrum 2-4%, berberine 1-5%, patchouli alcohol 2-4%, menthol 1-2%, alkyl glycoside 2-6%, tea saponin 0.5-1.5%, dipotassium glycyrrhizinate 1-3%, a deodorant 2-10%, ethanol 5-25% and corn flour 36.5-82.5%. The bacteriostatic foot powder not only can effectively improve foot hyperhidrosis and prevent and treat foot odour, but also can inhibit bacteria, diminish inflammation and resist allergy, and effectively treats tinea pedis. Meanwhile, the provided bacteriostatic foot powder is gentle in property, and is safe and non-irritant.

The invention provides a composition for skin allergy and impaired skin barrier and a preparation method thereof. The composition comprises the following components by weight percent: 8-12% of purslane extract, 3-7% of gentina root extract, 3-7% of sophora root extract, 3-7% of snowparsley extract, 3-7% of asiaticoside, 1-5% of densefruit pittany root-bark extract, 0.5-1.5% of artesunate, 1-3% oflicorice extract, 0.5-1.5% of ceramide, 0.3-0.9% of cholesterol, 0.2-0.6% of fatty acid, 15-27% of butanediol and 35-47% of deionized water. The composition disclosed by the invention mainly adopts traditional Chinese medicine components, is safe and effective, and has the effects of calming and relieving itching, relieving heat and diminishing inflammation and reducing swelling and removing dampness for facial allergy, hormone dependent dermatitis, acne rosacea and the like; and meanwhile, due to long-term use, the composition can achieve the effects of gradually improving erythema and desquamation, promoting keratinized cell differentiation maturation and repairing skin barrier to stabilize.

In various embodiments, the present disclosure pertains to a composition composed of chlophedianol and menthol, or method of use thereof, having a form of a chewable composition, a chewable gummy, a chewable tablet, a chewable candy, a soft chewable, a hard chewable, a tablet, a capsule, a quick dissolving tablet or capsule, a lozenge, an orally disintegrating tablet, and a liquid composition. In some embodiments, the composition is formulated to alleviate respiratory tract infection symptoms, symptoms cause by allergies, symptoms cause by the common cold, symptoms cause by acute bronchitis, symptoms cause by pneumonia, symptoms cause by pertussis, symptoms cause by influenza, symptoms cause by tuberculosis, post-infectious cough symptoms, dry cough symptoms, productive cough symptoms, non-productive cough symptoms, or coughing and coughing-related symptoms selected from the group consisting of throat soreness, muscle strains or soreness in the abdomen or throat, throat irritation, and lung irritation, or combinations thereof.